Back to Search Start Over

Maternal COVID-19 Vaccination and Prevention of Symptomatic Infection in Infants.

Authors :
Cardemil CV
Cao Y
Posavad CM
Badell ML
Bunge K
Mulligan MJ
Parameswaran L
Olson-Chen C
Novak RM
Brady RC
DeFranco E
Gerber JS
Pasetti M
Shriver M
Coler R
Berube B
Suthar MS
Moreno A
Gao F
Richardson BA
Beigi R
Brown E
Neuzil KM
Munoz FM
Source :
Pediatrics [Pediatrics] 2024 Mar 01; Vol. 153 (3).
Publication Year :
2024

Abstract

Background and Objectives: Maternal vaccination may prevent infant coronavirus disease 2019 (COVID-19). We aimed to quantify protection against infection from maternally derived vaccine-induced antibodies in the first 6 months of an infant's life.<br />Methods: Infants born to mothers vaccinated during pregnancy with 2 or 3 doses of a messenger RNA COVID-19 vaccine (nonboosted or boosted, respectively) had full-length spike (Spike) immunoglobulin G (IgG), pseudovirus 614D, and live virus D614G, and omicron BA.1 and BA.5 neutralizing antibody (nAb) titers measured at delivery. Infant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was determined by verified maternal-report and laboratory confirmation through prospective follow-up to 6 months of age between December 2021 and July 2022. The risk reduction for infection by dose group and antibody titer level was estimated in separate models.<br />Results: Infants of boosted mothers (n = 204) had significantly higher Spike IgG, pseudovirus, and live nAb titers at delivery than infants of nonboosted mothers (n = 271), and were 56% less likely to acquire infection in the first 6 months (P = .03). Irrespective of boost, for each 10-fold increase in Spike IgG titer at delivery, the infant's risk of acquiring infection was reduced by 47% (95% confidence interval 8%-70%; P = .02). Similarly, a 10-fold increase in pseudovirus titers against Wuhan Spike, and live virus nAb titers against D614G, and omicron BA.1 and BA.5 at delivery were associated with a 30%, 46%, 56%, and 60% risk reduction, respectively.<br />Conclusions: Higher transplacental binding and nAb titers substantially reduced the risk of SARS-CoV-2 infection in infants, and a booster dose amplified protection during a period of omicron predominance. Until infants are age-eligible for vaccination, maternal vaccination provides passive protection against symptomatic infection during early infancy.<br /> (Copyright © 2024 by the American Academy of Pediatrics.)

Details

Language :
English
ISSN :
1098-4275
Volume :
153
Issue :
3
Database :
MEDLINE
Journal :
Pediatrics
Publication Type :
Academic Journal
Accession number :
38332733
Full Text :
https://doi.org/10.1542/peds.2023-064252